Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $8.3350 (-0.48%) ($8.3350 - $8.3350) on Mon. Nov. 6, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.21% (three month average) | RSI | 69 | Latest Price | $8.3350(-0.48%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT advances 5.7% a day on average for past five trading days. | Weekly Trend | EDIT advances 8.2% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) ARKG(81%) XBI(80%) SPY(74%) ARKK(70%) IBUY(68%) | Factors Impacting EDIT price | EDIT will decline at least -2.105% in a week (0% probabilities). TBT(-25%) UUP(-13%) VXX(-10%) VIXM(2%) USO(5%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -2.105% (StdDev 4.21%) | Hourly BBV | 0.7 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $7.46(11.73%) | 10 Day Moving Average | $6.99(19.24%) | 20 Day Moving Average | $6.89(20.97%) | To recent high | -8.7% | To recent low | 33.1% | Market Cap | $518m | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |